TrialThe Lancet. Oncology2012

Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial.

Lei Chen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.